FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2400161037> ?p ?o ?g. }

• W2400161037 endingPage "42" @default.
• W2400161037 startingPage "37" @default.
• W2400161037 abstract "The standard primary treatment for advanced prostate cancer has been hormonal therapy since the 1940s. However, prostate cancer inevitably progresses to castration-resistant prostate cancer (CRPC) after a median duration of 18 months of androgen deprivation therapy. In patients with CRPC, docetaxel has been regarded as the standard treatment. However, survival advantages of docetaxel over other treatments are slim, and the need for new agents persists. In recent years, novel agents, including abiraterone, enzalutamide, cabazitaxel, radium-223, and sipuleucel-T, have been approved for the treatment of CRPC, and more such agents based on diverse mechanisms are under investigation or evaluation. In this article, the authors reviewed the current literature on recent advances in medical treatment of prostate cancer, especially CRPC. In addition, the authors elaborated on novel drugs for prostate cancer currently undergoing investigation and their mechanisms." @default.
• W2400161037 created "2016-06-24" @default.
• W2400161037 creator A5030579517 @default.
• W2400161037 creator A5061795624 @default.
• W2400161037 creator A5062231118 @default.
• W2400161037 creator A5067284897 @default.
• W2400161037 date "2016-06-01" @default.
• W2400161037 modified "2023-09-27" @default.
• W2400161037 title "New drugs in prostate cancer" @default.
• W2400161037 cites W1536264784 @default.
• W2400161037 cites W1542345927 @default.
• W2400161037 cites W1560691946 @default.
• W2400161037 cites W1694135770 @default.
• W2400161037 cites W1757407923 @default.
• W2400161037 cites W1932786078 @default.
• W2400161037 cites W1940135647 @default.
• W2400161037 cites W1968735621 @default.
• W2400161037 cites W1969398614 @default.
• W2400161037 cites W1970285863 @default.
• W2400161037 cites W1975181142 @default.
• W2400161037 cites W1975609403 @default.
• W2400161037 cites W1979811833 @default.
• W2400161037 cites W1983461177 @default.
• W2400161037 cites W2000460499 @default.
• W2400161037 cites W2002601689 @default.
• W2400161037 cites W2027902748 @default.
• W2400161037 cites W2051025382 @default.
• W2400161037 cites W2062817904 @default.
• W2400161037 cites W2070436739 @default.
• W2400161037 cites W2074497307 @default.
• W2400161037 cites W2077301757 @default.
• W2400161037 cites W2080748037 @default.
• W2400161037 cites W2094269170 @default.
• W2400161037 cites W2098706602 @default.
• W2400161037 cites W2103059478 @default.
• W2400161037 cites W2111987374 @default.
• W2400161037 cites W2113798012 @default.
• W2400161037 cites W2130088545 @default.
• W2400161037 cites W2130846254 @default.
• W2400161037 cites W2130955565 @default.
• W2400161037 cites W2148047944 @default.
• W2400161037 cites W2155846302 @default.
• W2400161037 cites W2158011521 @default.
• W2400161037 cites W2158219426 @default.
• W2400161037 cites W2164092182 @default.
• W2400161037 cites W2166507726 @default.
• W2400161037 cites W2169468059 @default.
• W2400161037 cites W2187721367 @default.
• W2400161037 cites W2206188372 @default.
• W2400161037 cites W2217920248 @default.
• W2400161037 cites W2235405584 @default.
• W2400161037 cites W2333614838 @default.
• W2400161037 cites W4245865627 @default.
• W2400161037 doi "https://doi.org/10.1016/j.prnil.2016.05.001" @default.
• W2400161037 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4916061" @default.
• W2400161037 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27358841" @default.
• W2400161037 hasPublicationYear "2016" @default.
• W2400161037 type Work @default.
• W2400161037 sameAs 2400161037 @default.
• W2400161037 citedByCount "22" @default.
• W2400161037 countsByYear W24001610372017 @default.
• W2400161037 countsByYear W24001610372018 @default.
• W2400161037 countsByYear W24001610372019 @default.
• W2400161037 countsByYear W24001610372020 @default.
• W2400161037 countsByYear W24001610372021 @default.
• W2400161037 countsByYear W24001610372022 @default.
• W2400161037 crossrefType "journal-article" @default.
• W2400161037 hasAuthorship W2400161037A5030579517 @default.
• W2400161037 hasAuthorship W2400161037A5061795624 @default.
• W2400161037 hasAuthorship W2400161037A5062231118 @default.
• W2400161037 hasAuthorship W2400161037A5067284897 @default.
• W2400161037 hasBestOaLocation W24001610371 @default.
• W2400161037 hasConcept C121608353 @default.
• W2400161037 hasConcept C126322002 @default.
• W2400161037 hasConcept C143998085 @default.
• W2400161037 hasConcept C2776421732 @default.
• W2400161037 hasConcept C2776551883 @default.
• W2400161037 hasConcept C2777783956 @default.
• W2400161037 hasConcept C2777899217 @default.
• W2400161037 hasConcept C2778971682 @default.
• W2400161037 hasConcept C2780192828 @default.
• W2400161037 hasConcept C2780737065 @default.
• W2400161037 hasConcept C2781190966 @default.
• W2400161037 hasConcept C61367390 @default.
• W2400161037 hasConcept C71924100 @default.
• W2400161037 hasConceptScore W2400161037C121608353 @default.
• W2400161037 hasConceptScore W2400161037C126322002 @default.
• W2400161037 hasConceptScore W2400161037C143998085 @default.
• W2400161037 hasConceptScore W2400161037C2776421732 @default.
• W2400161037 hasConceptScore W2400161037C2776551883 @default.
• W2400161037 hasConceptScore W2400161037C2777783956 @default.
• W2400161037 hasConceptScore W2400161037C2777899217 @default.
• W2400161037 hasConceptScore W2400161037C2778971682 @default.
• W2400161037 hasConceptScore W2400161037C2780192828 @default.
• W2400161037 hasConceptScore W2400161037C2780737065 @default.
• W2400161037 hasConceptScore W2400161037C2781190966 @default.
• W2400161037 hasConceptScore W2400161037C61367390 @default.
• W2400161037 hasConceptScore W2400161037C71924100 @default.

• next